Key result
Combined use of antitachycardia pacemakers and implanted defibrillators resulted in device interactions in 40% (4 of 10) of patients, requiring changes in pacemaker programming.
Why the study?
Does the combined use of permanent automatic antitachycardia pacemakers and implanted defibrillators lead to adverse device interactions in patients with recurrent monomorphic sustained ventricular tachycardia?
Observational (n=10)
Does the combined use of permanent automatic antitachycardia pacemakers and implanted defibrillators lead to adverse device interactions in patients with recurrent monomorphic sustained ventricular tachycardia?
The combined use of separate antitachycardia pacemakers and defibrillators frequently results in adverse device interactions requiring reprogramming, highlighting the clinical need for integrated devices.
Answers are grounded in this paper and cite their sources.
May cause interactions with separate devices; hypothesis-generating for integrated systems in recurrent VT.
We evaluated the combined use of permanent automatic antitachycardia pacemakers and implanted defibrillators in ten patients with recurrent monomorphic sustained ventricular tachycardia (VT). Pacemaker programming was VVI-T automatic burst in eight patients, VVI-T magnet mode in one patient, and VVI in one patient. Device interactions occurred in four patients, requiring changes in pacemaker programming. These included defibrillator multiple counting during pacing, inappropriate pacemaker bursts initiating VT, inappropriate reset of the pacemaker antitachycardia mode by defibrillation, defibrillator discharge after pacemaker VT termination, and defibrillator VT reinitiation. Two patients required pacemaker programming out of the antitachycardia mode, and two required a change in antitachycardia pacing parameters. Seven patients remain in automatic VVI-T and three in VVI modes. Mean follow-up is 13 months and all patients are alive. Thus, although pacemaker/defibrillator combinations function well for patients with more than one VT rate, device interactions occur frequently and may require pacemaker reprogramming or elimination of the overdrive mode. Combined use of these devices should be cautiously considered when single device therapy is unsatisfactory. Devices that combine both pacing and defibrillation features may reduce adverse interaction.
No takes yet. Share an insight, caveat, or question.
Ahern et al. (1991) conducted an observational in recurrent monomorphic sustained ventricular tachycardia (VT) (n=10). Combined use of permanent automatic antitachycardia pacemakers and implanted defibrillators was evaluated on Device interactions. Combined use of antitachycardia pacemakers and implanted defibrillators resulted in device interactions in 40% (4 of 10) of patients, requiring changes in pacemaker programming.
Synapse has enriched 10 related papers. Consider them for comparative context: